anti-GAD65 (aa286–300) TCR, pCDTCR1 (TCR-L022Z)

The vector of anti-GAD65 T cell receptor (TCR) is constructed for the engineering of T cell to target Human GAD65. The T cells are genetically modified through transduction with a retroviral vector expressing GAD65-specific T cell receptor. And the vector product was designed for the treatment of diabetes mellitus.

Datasheet   Add to Cart


  • Target
  • GAD65
  • Target Species
  • Human
  • Epitope
  • GAD65[286–300]
  • Format
  • Non-modified
  • Targeting Diseases
  • Diabetes mellitus
  • Vector Name
  • pCDTCR1
  • Vector Length
  • 8kb
  • Vector Type
  • Lentiviral
  • TCR Host Animal
  • Human


  • Official Symbol
  • GAD2
  • Introduction
  • This gene encodes one of several forms of glutamic acid decarboxylase, identified as a major autoantigen in insulin-dependent diabetes. The enzyme encoded is responsible for catalyzing the production of gamma-aminobutyric acid from L-glutamic acid. A pathogenic role for this enzyme has been identified in the human pancreas since it has been identified as an autoantibody and an autoreactive T cell target in insulin-dependent diabetes. This gene may also play a role in the stiff man syndrome. Alternative splicing results in multiple transcript variants that encode the same protein.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Related Products

Online Inquiry


45-1 Ramsey Road, Shirley, NY 11967, USA
Call us at:
USA: 1-631-381-2994
Europe: 44-207-097-1828
Fax: 1-631-207-8356

Online Inquiry

For any technical issues or products/services related questions, please leave your contacts as below, and our team will contact you at earliest convenience to let you know how we can be involved in your projects.

  • Verification code
    Click image to refresh the verification code.

Key Updates

Receive the latest news and insights to your inbox.